Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v5-FR
Language English French
Date Updated 2020-11-10 2020-11-05
Drug Identification Number 02265982 02265982
Brand name BLEOMYCIN FOR INJECTION BLEOMYCIN FOR INJECTION
Common or Proper name Bleomycin for Injection Bleomycin for Injection
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients BLEOMYCIN BLEOMYCIN
Strength(s) 15UNIT 15UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAPLEURAL INTRAMUSCULAR INTRAPLEURAL INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAPLEURAL INTRAMUSCULAR INTRAPLEURAL INTRAVENOUS SUBCUTANEOUS
Packaging size 10 mL 10 mL
ATC code L01DC L01DC
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-10-16 2020-10-16
Actual start date
Estimated end date 2020-11-09 2020-11-09
Actual end date 2020-11-09 2020-11-09
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be encountering a supply interruption on our Bleomycin for Injection, 15 Units, SD Vial, 10 mL. Estimated Stockout Date October 16, 2020. Please note that the stockout date may vary by region, please check your local distribution centre for availability. UPDATE 11/05: Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Bleomycin for Injection, 15 Units, SD Vial, 10 mL have been released and will be available at all distribution centers across the country early next week. November 9, 2020 Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be encountering a supply interruption on our Bleomycin for Injection, 15 Units, SD Vial, 10 mL. Estimated Stockout Date October 16, 2020. Please note that the stockout date may vary by region, please check your local distribution centre for availability. UPDATE 11/05: Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Bleomycin for Injection, 15 Units, SD Vial, 10 mL have been released and will be available at all distribution centers across the country early next week. November 9, 2020
Health Canada comments